Connect Biopharma Holdings Ltd (CNTB)
Earnings
Annual and quarterly EPS data presented alongside analyst estimates, earnings surprises, and historical growth statistics. The side-by-side view of reported versus estimated EPS — combined with surprise percentage and report timing — allows investors to assess whether a company consistently beats, meets, or misses market expectations, and how that track record has evolved across full economic cycles.
Earnings annual
Fiscal date endingReported EPS
Dec 31, 2021
-$0.50
Dec 31, 2024
-$1.86
Dec 31, 2025
-$1
Mar 31, 2026
-$0.27
Jun 30, 2026
-$0.54
Sep 30, 2026
-$0.54
Calculation
Growth rate
-1.53%
Average
-$0.78
Maximum
Mar 31, 2026
-$0.27
Minimum
Dec 31, 2024
-$1.86
Median
Jun 30, 2026
-$0.54
Earnings quarterly
| Fiscal date ending | Dec 31, 2021 |
| Reported date | Mar 31, 2022 |
| Report time | Post market |
| Reported EPS | -$0.50 |
| Estimated EPS | -$0.52 |
| Surprise | $0.02 |
| Surprise (%) | 3.85% |
| Fiscal date ending | Jun 30, 2022 |
| Reported date | Sep 13, 2022 |
| Report time | Post market |
| Reported EPS | -$0.90 |
| Estimated EPS | -$0.21 |
| Surprise | -$0.69 |
| Surprise (%) | -328.57% |
| Fiscal date ending | Jun 30, 2023 |
| Reported date | Sep 12, 2023 |
| Report time | Post market |
| Reported EPS | -$0.54 |
| Estimated EPS | -$6.92 |
| Surprise | $6.38 |
| Surprise (%) | 92.20% |
| Fiscal date ending | Dec 31, 2024 |
| Reported date | Mar 31, 2025 |
| Report time | Pre market |
| Reported EPS | -$0.42 |
| Estimated EPS | $0 |
| Surprise | -$0.42 |
| Surprise (%) | -% |
| Fiscal date ending | Mar 31, 2025 |
| Reported date | May 15, 2025 |
| Report time | Pre market |
| Reported EPS | -$0.19 |
| Estimated EPS | -$0.26 |
| Surprise | $0.07 |
| Surprise (%) | 26.92% |
| Fiscal date ending | Jun 30, 2025 |
| Reported date | Aug 13, 2025 |
| Report time | Pre market |
| Reported EPS | -$0.23 |
| Estimated EPS | -$0.22 |
| Surprise | -$0.01 |
| Surprise (%) | -4.55% |
| Fiscal date ending | Sep 30, 2025 |
| Reported date | Nov 12, 2025 |
| Report time | Pre market |
| Reported EPS | -$0.31 |
| Estimated EPS | -$0.23 |
| Surprise | -$0.08 |
| Surprise (%) | -34.78% |
| Fiscal date ending | Dec 31, 2025 |
| Reported date | Mar 31, 2026 |
| Report time | Post market |
| Reported EPS | -$0.27 |
| Estimated EPS | -$0.30 |
| Surprise | $0.03 |
| Surprise (%) | 10% |
| Fiscal date ending | Mar 31, 2026 |
| Reported date | May 12, 2026 |
| Report time | Pre market |
| Reported EPS | -$0.27 |
| Estimated EPS | -$0.28 |
| Surprise | $0.01 |
| Surprise (%) | 4.60% |
| Fiscal date ending | Jun 30, 2026 |
| Reported date | Aug 12, 2026 |
| Report time | Post market |
| Reported EPS | -$0.27 |
| Estimated EPS | -$0.32 |
| Surprise | $0.05 |
| Surprise (%) | 15.63% |
| Fiscal date ending | Sep 30, 2026 |
| Reported date | Nov 11, 2026 |
| Report time | Pre market |
| Reported EPS | - |
| Estimated EPS | -$0.27 |
| Surprise | $0 |
| Surprise (%) | -% |
Calculation
Growth rate
100.00%
Average
-$0.39
Maximum
Sep 30, 2026
-
Minimum
Jun 30, 2022
-$0.90
Median
Dec 31, 2025
-$0.27